สถาบันวิจัยวิทยาศาสตร์สาธารณสุข

National Institute of Health of Thailand

Authors : Emily S. Abernathy,1 Judith M. Hu¨bschen,2 Claude P. Muller,2 Li Jin,3 David Brown,3 Katsuhiro Komase,4 Yoshio Mori,4Wenbo Xu,5 Zhen Zhu,5 Marilda M. Siqueira,6 Sergey Shulga,7 Nina Tikhonova,7 Sirima Pattamadilok,8 Patcha Incomserb,8 Sheilagh B. Smit,9 Chantal Akoua-Koffi,10 Josephine Bwogi,11 Wilina W. L. Lim,12 Gibson K. S. Woo,12 Hinda Triki,13 Youngmee Jee,14 Mick N. Mulders,15 Ana Maria Bispo de Filippis,16 Hinda Ahmed,17 Nalini Ramamurty,18David Featherstone,19 and Joseph P. Icenogle1

 

Affiliations : 

1 Division of Viral Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
2 Institute of Immunology, Centre de Recherche Public-Sante´ Laboratorie National de Sante´, Luxembourg
3 Virus Reference Department, Centre for Infections, Health Protection Agency, London, United Kingdom
4 Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan
5 National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing
6 Measles National Reference Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Ministry of Health, Rio de Janeiro, Brazil
7 Gabrichevsky G.N. Research Institute for Epidemiology and Microbiology, Moscow, Russia
8 National Institute of Health, Department of Medical Sciences, Nonthaburi, Thailand
9 Vaccine Preventable Virus Infections, National Institute for Communicable Diseases, Sandringham, South Africa
10 Regional Reference Laboratory for Measles/Rubella, Institut Pasteur de Coˆte d'Ivoire, Abidjan, Coˆte d'Ivoire
11 Expanded Program for Immunization Laboratory, Uganda Virus Research Institute, Ministry of Health, Entebbe, Uganda
12 Public Health Laboratory Services, Centre for Health Protection, Department of Health, Kowloon, Hong Kong, China
13 Laboratory of Clinical Virology, Institut Pateur de Tunis, Tunisia
14 World Health Organization (WHO) Regional Office for the Western Pacific, Manila, Philippines
15 WHO Regional Office for Europe, Copenhagen, Denmark
16 WHO, Pan American Health Organization, Washington, D.C
17 WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt
18 WHO Regional Office for South-East Asia, New Delhi, India
19 Department of Immunization, Vaccines, and Biologicals, Family and Community Health Cluster, WHO, Geneva, Switzerland

Source :

The Journal of Infectious Diseases 2011; 204: S524–S532

Language : English

Abstract :

 
 

      The suspected measles case definition captures rubella cases. Therefore, measles surveillance will be improved in the course of the control and eventual elimination of rubella transmission. One aspect of rubella control, virologic surveillance, is reviewed here. A systematic nomenclature for rubella viruses (RVs) based on 13 genotypes has been established and is updated when warranted by increases in information about RVs. From 2005 through 2010, the genotypes of RVs most frequently reported were 1E, 1G, and 2B, and genotypes 1a, 1B, 1C, 1h, 1j, and 2C were less frequently reported. Virologic surveillance can support rubella control and elimination. Synopses of rubella virologic surveillance in various countries, regions, and globally are given, including characterization of viruses from imported cases in a country that has eliminated rubella and studies of endemic viruses circulating in countries without rubella control objectives. Current challenges are discussed.